2013
DOI: 10.1016/j.vaccine.2013.06.089
|View full text |Cite
|
Sign up to set email alerts
|

High prevalence of antibodies against canine adenovirus (CAV) type 2 in domestic dog populations in South Africa precludes the use of CAV-based recombinant rabies vaccines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
4
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 37 publications
1
4
0
Order By: Relevance
“…The high prevalence of CAdV infection detected is in agreement with the prevalence of CAdV infection recently observed in serologic surveys carried out on domestic dogs and free-ranging canids (Akerstedt et al, 2010;Belsare and Gompper, 2013;Gür and Acar, 2009;Wright et al, 2013), which confirm the ubiquitous diffusion of CAdV in receptive hosts in different parts of the world. The significant prevalence of CAdV-1 and CAdV-2 infection in the dogs analysed in this study support the hypothesis of a widespread circulation of these viruses in the canine population.…”
Section: Discussionsupporting
confidence: 89%
“…The high prevalence of CAdV infection detected is in agreement with the prevalence of CAdV infection recently observed in serologic surveys carried out on domestic dogs and free-ranging canids (Akerstedt et al, 2010;Belsare and Gompper, 2013;Gür and Acar, 2009;Wright et al, 2013), which confirm the ubiquitous diffusion of CAdV in receptive hosts in different parts of the world. The significant prevalence of CAdV-1 and CAdV-2 infection in the dogs analysed in this study support the hypothesis of a widespread circulation of these viruses in the canine population.…”
Section: Discussionsupporting
confidence: 89%
“…However, Wright et al showed that pre-existing antibodies against CAV, naturally occurring in South Africa, inhibited the development of VNA against rabies in dogs immunized with CAV-2-E3Δ-RGP. All dogs, except one which received prior vaccination against CAV and were then immunized with CAV-2-E3Δ-RGP orally, developed rabies after challenge [ 52 ].…”
Section: Efficacymentioning
confidence: 99%
“…These findings could have important implications for dog disease control programmes and for the selection of appropriate management approaches that might be considered in efforts to reduce the likelihood of cross‐species transmission of viral pathogens that occur at relatively high prevalence in reservoir populations (Belsare, ; Wright et al., ). Canine vaccination has been recommended as a mechanism for reducing the prevalence and incidence of viral diseases in dogs and has been used in conservation management of wild carnivore populations (Cleaveland et al., ; Knobel et al., 2014).…”
Section: Discussionmentioning
confidence: 99%